Shanghai Jiao Tong University and Yale University jointly launched an immune-metabolic institute in Shanghai on March 23.

The institute, the first of its kind to be established by Yale University outside of the United States, will conduct research into the immune system's metabolism, a field related to the 2018 Nobel Medicine Prize awarded for cancer research.

The institute is being supported by Yale’s Department of Immunobiology, a major department of Yale School of Medicine, which has five members of the National Academy of Sciences/Medicine in the US, and its many academic indicators rank first in the world.

Richard Flavell, an academician at the National Academy of Sciences in the US and founder of the immunology school at Yale, and Su Bing, director of the Shanghai Institute of Immunology, School of Medicine of Shanghai Jiao Tong University, will serve as the deans of the institute.

“We will strive to build the institute into the most competitive institution working at immunity and metabolism research and facilitate the innovative development of Shanghai,” said Flavell.

The first phase of the institute is located in the old campus of Shanghai Jiao Tong University of Medicine. The second phase is expected to be located at the new campus in Pudong New Area.